betaxolol hydrochloride - Profile
What are the generic drug sources for betaxolol hydrochloride and what is the scope of freedom to operate?
Betaxolol hydrochloride
is the generic ingredient in six branded drugs marketed by Apotex Inc, Chartwell Rx, Eurofarma, Pharmobedient, Sandoz, Novartis, Epic Pharma, Kvk Tech, Sanofi Aventis Us, and Alcon, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.Summary for betaxolol hydrochloride
| US Patents: | 0 |
| Tradenames: | 6 |
| Applicants: | 10 |
| NDAs: | 11 |
US Patents and Regulatory Information for betaxolol hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Inc | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075446-001 | Sep 28, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 078694-001 | Nov 16, 2009 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Eurofarma | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075630-001 | Apr 12, 2001 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075386-001 | Jun 30, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | AT | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novartis | BETOPTIC S | betaxolol hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 019845-001 | Dec 29, 1989 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Epic Pharma | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | TABLET;ORAL | 075541-001 | Oct 22, 1999 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for betaxolol hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sandoz | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | 4,252,984 | ⤷ Start Trial |
| Novartis | BETOPTIC S | betaxolol hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 019845-001 | Dec 29, 1989 | 4,342,783 | ⤷ Start Trial |
| Sandoz | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | 4,342,783 | ⤷ Start Trial |
| Sandoz | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | 4,311,708 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
